Results 251 to 260 of about 217,774 (305)

Fibroblast Growth Factor Receptor 4 Promotes Triple-Negative Breast Cancer Progression via Regulating Fatty Acid Metabolism Through the AKT/RYR2 Signaling. [PDF]

Cancer Med
Ye J, Wu S, Quan Q, Ye F, Zhang J, Song C, Fan Y, Cao H, Tang H, Zhao J.   +9 more
europepmc   +1 more source

Fibroblast growth factor receptor signaling in estrogen receptor-positive breast cancer: mechanisms and role in endocrine resistance. [PDF]

Front Oncol
Marin A, Morales F, Walbaum B.
europepmc   +1 more source

A Case of Fibroblast Growth Factor Receptor Fusion-Positive Intrahepatic Cholangiocarcinoma With Humoral Hypercalcemia of Malignancy. [PDF]

Cureus
Chauhan A, Likasitwatanakul P, Ahmed A, Sibley SD.   +3 more
europepmc   +1 more source

Retraction Note: Fibroblast growth factor receptor 1 is principally responsible for fibroblast growth factor 2-induced catabolic activities in human articular chondrocytes

Arthritis Research & Therapy
Dongyao Yan, Di Chen, Simon M Cool, Andre J van Wijnen, Katalin Mikecz, Gillian Murphy, Hee-Jeong Im   +6 more
doaj   +1 more source

Fibroblast growth factor receptor 1 gene (FGFR1) amplification in non-small cell lung cancer (NSCLC) by real-time PCR. [PDF]

Caspian J Intern Med
Homayounfar S, Ayatollahi H, Ferns G, Hemmatan Attarbashi R, Gharib M, Sheikhi M, Khoshnegah Z, Siyadat P, Jafarian A.   +8 more
europepmc   +1 more source

IRREVERSIBLE RETINAL PIGMENT EPITHELIUM TOXICITY ASSOCIATED WITH FIBROBLAST GROWTH FACTOR RECEPTOR INHIBITOR THERAPY. [PDF]

Retin Cases Brief Rep
Houghton OM.
europepmc   +1 more source

Identification and Confirmation of Myeloid/Lymphoid Neoplasms with Fibroblast Growth Factor Receptor 1 Rearrangement and Characterization of Treatment Patterns and Outcomes in a Real-World Setting: A US Retrospective Chart Review.

Acta Haematol
Parasuraman S, Saverno K, Zimmerman Savill KM, Colucci P.   +3 more
europepmc   +1 more source

Molecular Targeting of the Fibroblast Growth Factor Receptor Pathway across Various Cancers. [PDF]

Int J Mol Sci
Shan KS, Dalal S, Thaw Dar NN, McLish O, Salzberg M, Pico BA.   +5 more
europepmc   +1 more source